Ironwood Pharmaceuticals Inc.

IRWD | NASDAQ

$4.46

+$0.05 (+1.13%)

Sep 22, 2026, 1:29 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	296.15M	351.41M	442.74M	410.6M	413.75M	389.52M
Cost of Revenue	n/a	7.55M	6.15M	1.42M	70.41M	3.14M
Gross Profit	296.15M	343.86M	436.59M	409.18M	343.35M	386.39M
Operating Income	118.76M	93.12M	-945.43M	250.34M	232.26M	142.94M
Interest Income	4.08M	4.47M	18.97M	9.5M	726K	1.5M
Pretax Income	70.03M	65.2M	-948.07M	252.42M	200.66M	108.86M
Net Income	24.02M	880K	-1B	175.07M	528.45M	106.18M
Selling & General & Admin	82.26M	n/a	n/a	115.99M	n/a	140M
Research & Development	95.14M	111.42M	116.09M	44.27M	70.41M	88.06M
Other Expenses	n/a	139.31M	1.27B	-1.42M	40.68M	15.38M
Operating Expenses	177.39M	250.73M	1.38B	158.84M	111.09M	243.45M
Interest Expense	32.75M	33.03M	21.63M	7.6M	31.15M	29.48M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	177.39M	258.29M	1.39B	160.26M	181.49M	246.58M
Income Tax Expense	46.01M	64.32M	83.49M	77.36M	-327.79M	2.69M
Shares Outstanding (Basic)	162.22M	159.08M	155.44M	154.37M	162.25M	159.43M
Shares Outstanding (Diluted)	177.76M	160.08M	155.44M	186.31M	164.42M	160.66M
EPS (Basic)	0.15	0.01	-6.45	1.13	3.26	0.67
EPS (Diluted)	0.15	0.01	-6.45	0.96	3.21	0.66
EBITDA	104.65M	97.73M	197.41M	261.44M	233.74M	141.9M
EBIT	102.77M	95.72M	195.84M	260.02M	232.22M	138.34M
Depreciation & Amortization	1.88M	2.01M	1.58M	1.42M	1.52M	3.56M